HCA Healthcare, Inc.

HCA Healthcare, Inc. is the largest investor-owned hospital operator in the United States. Through 190 hospitals, 121 freestanding ambulatory surgery centers and 31 freestanding endoscopy centers across 19 states and England, it admitted roughly 2.3 million patients in 2025 and earned $75.6 billion of revenue — more than any other for-profit hospital system. It is a scale business in a scale industry, and it has spent two decades assembling the density, the physician networks and the centralized back office that its smaller rivals can only envy.

This is a story about a compounding franchise interrupted by a policy shock. HCA's earnings have risen every year since the pandemic, powered by an ageing population, pricing and a disciplined cost machine. Then, at the end of 2025, the enhanced premium tax credits that subsidised the Affordable Care Act insurance exchanges expired. Patients did not drop out of the system; they migrated into it uninsured, and HCA discovered that uninsured patients still show up, still consume care, and now pay far less. At the same time the Medicaid "directed payment" programmes that several states had used to top up hospital reimbursement became a live policy target in Washington. Against 2026 revenue of about $78 billion on a trailing basis, the company is being asked to absorb a payer-mix deterioration that management originally sized at a few hundred million dollars and has since marked materially higher.

The file turns on a single question: is 2026 a transient hole in the earnings progression, or the year the margin structure reset lower? HCA trades at about 13 times trailing earnings and under nine times trailing EBITDA — undemanding multiples that already assume the market is sceptical. The debates below are the ones that decide whether that scepticism is warranted.